Evidence map›Paper›PMID 42108832›Full record

ArticleBiotechnology and bioengineering2026

High-Level Production of Ergothioneine in Yarrowia lipolytica via Systematic Metabolic Engineering Strategies.

Qing Chen, Jianan Li, Kaixin Liu, Yang Wu, Xiujuan Li, Lihui Zhang, Dongsheng Guo

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qing ChenSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.
Jianan LiSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.
Kaixin LiuSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.
Yang WuSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.
Xiujuan LiSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.ORCID 0000-0001-7642-721X
Lihui ZhangSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.ORCID 0000-0002-2323-2408
Dongsheng GuoSchool of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.ORCID 0009-0009-5078-4898

Funding

National Key Research and Development Program of China 2024YFA0917800Natural Science Fund for Colleges and Universities in Jiangsu Province 24KJB530017
6 · The paper itself

Abstract

Ergothioneine (ERG), a food-derived antioxidant and cytoprotectant, has broad application prospects in food, nutraceuticals, cosmetics, and biomedical fields. The growing market demand for ERG has driven the development of microbial cell factories as a sustainable production platform. However, the biosynthetic production of ERG faces challenges including poor substrate channeling, limited precursor supply, and potential inhibition by intracellular product accumulation. To construct a promising cell factory for high-level ERG production, firstly, the ERG biosynthetic pathway from Trichoderma reesei was heterologously expressed in Y. lipolytica Po1f (Δku70). Secondly, the application of Tregt1-Tregt2 fusion with a flexible (GGGGS)₂ linker and multi-copy integration led to an ERG production of 618.97 mg/L, an 83% improvement. Then, carbon flux was systematically redirected toward ERG production via modular engineering to enhance the precursor supply. Finally, fermentation conditions were optimized, resulting in an ERG production of 1075.27 mg/L in shake flask after 120 h fermentation. When scaled up to 5 L bioreactor, the strain achieved a final ERG production of 8.03 g/L within 168 h (47.79 mg/L/h), the highest reported to date without the supplementation of exogenous precursors. This study provides an effective strategy for utilizing Y. lipolytica as a microbial cell factory for ERG biosynthesis.

Indexed as

ErgothioneineMetabolic EngineeringYarrowiaBioreactorsBiosynthetic PathwaysFermentationHypocrealesTrichodermaErgothioneineergothioneinefermentation optimizationmetabolic engineeringsystems metabolic engineeringYarrowia lipolytica

Identifiers

PMID42108832
PMCPMC13397179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.